ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

Use of immune checkpoint inhibitors (ICIs) as cancer immunotherapy advances rapidly in the clinic. Despite their therapeutic benefits, ICIs can cause clinically significant immune-related adverse events (irAEs), including myocarditis. However, the cellular and molecular mechanisms regulating irAE re...

Descripción completa

Detalles Bibliográficos
Autores principales: Horiguchi, Haruki, Kadomatsu, Tsuyoshi, Yamashita, Tomoya, Yumoto, Shinsei, Terada, Kazutoyo, Sato, Michio, Morinaga, Jun, Miyata, Keishi, Oike, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517162/
https://www.ncbi.nlm.nih.gov/pubmed/37736764
http://dx.doi.org/10.1038/s42003-023-05338-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517162/
https://www.ncbi.nlm.nih.gov/pubmed/37736764
http://dx.doi.org/10.1038/s42003-023-05338-4

Ejemplares similares